-
in discovering potential therapeutic candidates to target mitochondria vulnerability, including a nucleoside analog, small GTPase inhibitor, natural plant extract, monoclonal and bispecific antibodies
-
in discovering potential therapeutic candidates to target mitochondria vulnerability, including a nucleoside analog, small GTPase inhibitor, natural plant extract, and monoclonal and bispecific
-
conduct research in discovering potential therapeutic candidates to target mitochondria vulnerability, including a nucleoside analog, small GTPase inhibitor, natural plant extract, and monoclonal and
-
computational biologists. Career Development : Over the last two decades, the lab has mentored many postdoctoral researchers, fellows, graduate students. Dr. van den Brink has mentored over 60 postdocs, and
-
computational biologists. Career Development : Over the last two decades, the lab has mentored many postdoctoral researchers, fellows, graduate students. Dr. van den Brink has mentored over 60 postdocs, and
-
computational biologists. Career Development : Over the last two decades, the lab has mentored many postdoctoral researchers, fellows, graduate students. Dr. van den Brink has mentored over 60 postdocs, and